Tech Company Financing Transactions
EnBiotix Funding Round
On 5/16/2016, EnBiotix secured Series A funding from Apeiron Holdings and Wired Holdings Investment Corp..
Transaction Overview
Company Name
Announced On
5/16/2016
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Wired Holdings Investment Corp. (Roberto Guttman)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
77 Massachusetts Ave.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
EnBiotix is a product-focused bioengineering company commercializing anti-infective inventions of EnBiotix co-founder and SAB Chair Professor James J. Collins.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Wager
Vice President
Diane Joseph-McCarthy
VP - Bus. Development
Michael Garrett
VP - Bus. Development
Benjamin Perrone
Browse more venture capital transactions:
Prev: 5/16/2016: ProviaLabs venture capital transaction
Next: 5/16/2016: BioIQ venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs